FRANKFURT, Germany (Reuters) — Bayer beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings lat week, providing a respite for chief executive officer Bill Anderson’s turnaround efforts. The company also lowered its full-year earnings outlook, citing negative currency effects, but retained its operating forecast. The company’s quarterly earnings before interest, taxes, […] Read more
Tag Archives Bayer
Getting ahead of anthracnose in lentils
With lentil acreages expected to be up this year, getting on top of any anthracnose infestation early and with the latest tools should be top of mind for producers, says Kate Hadley, a marketing agronomist with Bayer. “Lentil acres are going to be up over last year,” Hadley said. “It seems like everyone’s seeding some […] Read more
Bayer confirms 2024 outlook
FRANKFURT, Germany (Reuters) — Bayer has confirmed its full-year forecast for earnings and cash flow despite slow business at its crop science and consumer health divisions. “Our Crop Science and Consumer Health divisions expect a slow start to the year due to market dynamics, but we feel confident in our full-year targets and the direction […] Read more
Major Bayer shareholder backs CEO’s strategy
Company has angered some shareholders with its plan to put breakup on hold while focusing on internal restructuring
FRANKFURT, Germany (Reuters) — Major Bayer shareholder Harris Associates has come out in strong support of the drug maker’s decision to suspend work on breaking up the diversified group, giving breathing room to its embattled chief executive officer. The endorsement takes some pressure off CEO Bill Anderson, who had earlier said he will pause for […] Read more
Bayer postpones breakup amidst financial woes
Company says it needs time to reduce debt, deal with legal challenges, pursue more job cuts and improve decision making
FRANKFURT, Germany (Reuters) — Bayer will hold off on plans to break apart the group for up to three years so that the new chief executive officer can focus on problems including debt and litigation. The move leaves investors dubious about whether enough is being done to revive the company’s fortunes. “Our answer is ‘not […] Read more
U.S. court cancels dicamba approval
CHICAGO, Ill. (Reuters) — A U.S. court has nullified the government’s latest approvals of certain agricultural herbicides sold by Bayer, BASF and Syngenta, fueling uncertainty among farmers who spray the products on soybeans and cotton genetically modified to resist them. Environmental activists cheered the court for halting use of the dicamba-based herbicides, which are known […] Read more
U.S. court blocks glyphosate labels
REUTERS — A divided federal appeals court said California cannot require businesses to warn consumers about the potential dangers of glyphosate, an ingredient in Roundup that has been linked to cancer. Upholding a permanent injunction, the ninth United States Circuit Court of Appeals in San Francisco found it unconstitutional to force Bayer’s Monsanto unit, which […] Read more
Bayer will consider breakup
Speaking to reporters at Bayer’s headquarters in Leverkusen, incoming CEO Bill Anderson offered clues as to his vision for the company, stressing a focus on results and advancing science, while keeping open the question of a breakup.
Bayer appeals Roundup ruling
(Reuters) — Bayer has asked California’s Supreme Court to review a decision awarding US$20.5 million to a groundskeeper who claimed the company’s Roundup herbicide caused his cancer, arguing the ruling was at odds with federal law and settled legal principles. Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, said […] Read more
Bayer glyphosate deal doesn’t apply to Canada
Bayer is committing more than US $10 billion to resolve U.S. lawsuits connected to Roundup, the company announced today. But the agreements, between Bayer and numerous law firms in America, don’t apply to potential class action lawsuits in Canada, said Tony Merchant, founder of Merchant Law Group. “We don’t really know, right now, where this […] Read more
